SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-023765
Filing Date
2020-11-13
Accepted
2020-11-13 10:09:35
Documents
51
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q relv20200930_10q.htm 10-Q 1281250
2 EXHIBIT 31.1 ex_212639.htm EX-31.1 11023
3 EXHIBIT 31.2 ex_212640.htm EX-31.2 11173
4 EXHIBIT 32 ex_212641.htm EX-32 6794
  Complete submission text file 0001437749-20-023765.txt   4691516

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT relv-20200930.xml EX-101.INS 841336
6 XBRL TAXONOMY EXTENSION SCHEMA relv-20200930.xsd EX-101.SCH 42228
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE relv-20200930_cal.xml EX-101.CAL 47277
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE relv-20200930_def.xml EX-101.DEF 302810
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE relv-20200930_lab.xml EX-101.LAB 275995
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE relv-20200930_pre.xml EX-101.PRE 319529
Mailing Address 136 CHESTERFIELD INDUSTRIAL BLVD P O BOX 405 CHESTERFIELD MO 63006-0405
Business Address 136 CHESTERFIELD INDUSTRIAL BLVD P O BOX 405 CHESTERFIELD MO 63006-0405 636-537-9715
RELIV INTERNATIONAL INC (Filer) CIK: 0000768710 (see all company filings)

IRS No.: 371172197 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19932 | Film No.: 201309588
SIC: 2834 Pharmaceutical Preparations